Type 1 Diabetes Clinical Trial
Official title:
Reducing Stress in Adolescents and Young Adults With T1D to Improve Diabetes Care
Adolescence and young adulthood may be particularly stressful developmental periods due to
the numerous transitions into new roles and the need for increased independence. Stress can
affect metabolic control in older adolescents and young adults with T1D directly through its
impact on cortisol and other hormones that affect insulin metabolism.
The proposed study is a pilot randomized clinical trial using a three-group randomized,
repeated measures design to assess the efficacy of two treatments (Mindfulness Based Stress
Reduction (MBSR) and Cognitive Behavioral Therapy or (CBT) versus an attention control
condition for older adolescents and young adults with poorly controlled Type 1 diabetes. As
a pilot study, the goal of the research is to test recruitment and retention procedures,
finalize intervention measures, training, and fidelity protocols, and estimate effect sizes
for a larger clinical trial.
This study will use a randomized, repeated measures design. A sample of 125 participants
will be recruited and consented from the Children's Hospital of Michigan and outpatient
diabetes clinics affiliated with the Detroit Medical Center. 108 will be randomized to one
of three treatment conditions (remaining participants are expected to consent but not enroll
or fail to initiate treatment). These participants will be enrolled in 3 cohorts of 30-36
participants.
Measures will be administered at 3 home-based study visits to maximize participant
convenience. The initial study visit (Visit 1) will be scheduled at the beginning of the
study. Visit 2 will coincide with the end of treatment which is approximately 3 months after
the initial study visit. Visit 3 is the 3-month follow up and will be scheduled about 6
months after the initial study visit. At each visit, participants will complete
questionnaires assessing their current diabetes management, stressors, quality of life,
mental health, and demographic characteristics. These questionnaires will be completed using
Qualtrics accessed via the internet on a university laptop computer. A research assistant
will download the participant's glucose meter to obtain the frequency of blood glucose
testing during the two weeks preceding data collection. The research assistant will also
assist participants with providing a blood sample via fingerstick (HbA1c) and saliva samples
by mouth (cortisol, Visits 1 and 2 only). All participants will be asked to take part in an
exit interview at Visit 3 to obtain feedback on the treatment they received.
After Visit 1, participants will be randomized using a 1:1:1 ratio to MBSR, CBT, or Diabetes
Support and Education (DSE). All three treatments are group format meeting (10-12
participants per group) for nine consecutive weeks at a location convenient to the
participants. In MBSR treatment focuses on the instruction and practice of mindfulness
techniques, such as meditation and yoga, and the application of these practices to everyday
activities. CBT utilizes activities to understand how thoughts affect emotions and
behaviors, the application of these activities to current stressors, and strategies to apply
these new skills to future stressors. The DSE group is the attention control condition; DSE
participants will receive diabetes education via a support group format. All group sessions
will be audiotaped for treatment fidelity monitoring and assessment. There are no planned
research interventions for the DSE group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A | |
Completed |
NCT02750527 -
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
|